subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: Advanced Pancreatic Carcinoma

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:91820602

object_name: Advanced Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage III Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:91820602

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:91820602

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:91820602

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:91820602

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C5389886

subject_name: hyaluronidase-zzxf

object_name: Advanced Sarcoma


subject: UMLS:C5389886

object_name: Advanced Breast Carcinoma


subject: UMLS:C5389886

object_name: Advanced Prostate Carcinoma


subject: UMLS:C5389886

object_name: Advanced Pancreatic Carcinoma


subject: UMLS:C5389886

object_name: Advanced Ovarian Carcinoma


subject: UMLS:C5389886

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C5389886

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C5389886

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C5389886

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5389886

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C5389886

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C5389886

object_name: Prostate cancer recurrent


subject: UMLS:C5389886

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5389886

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5389886

object_name: Recurrent ovarian cancer


subject: UMLS:C5389886

object_name: Breast cancer recurrent


subject: UMLS:C5389886

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Advanced Sarcoma


subject: UNII:K16AIQ8CTM

object_name: Advanced Breast Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Advanced Prostate Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Advanced Pancreatic Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Advanced Ovarian Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637

object_name: Advanced Malignant Solid Neoplasm

tested_intervention: yes


subject: CHEBI:63637

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:63637

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:63637

object_name: Prostate cancer recurrent


subject: CHEBI:63637

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:63637

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:63637

object_name: Recurrent ovarian cancer


subject: CHEBI:63637

object_name: Breast cancer recurrent


subject: CHEBI:63637

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Advanced Sarcoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Advanced Breast Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Advanced Prostate Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Advanced Pancreatic Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Advanced Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Weight loss


subject: CHEBI:194186

object_name: Weight Loss, CTCAE


subject: CHEBI:194186

object_name: Weight Gain


subject: CHEBI:194186

object_name: Weight Gain, CTCAE


subject: MESH:C000598421

object_name: Type 2 diabetes treated with insulin


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB

object_name: superficial urinary bladder carcinoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Nausea, CTCAE_5


subject: CHEBI:119915

object_name: Nausea


subject: CHEBI:119915

object_name: Nausea, CTCAE_3


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: staphylococcal infection


subject: CHEBI:29007

object_name: central nervous system infectious disorder


subject: CHEBI:29007

object_name: Coagulase negative staphylococcal infection


subject: CHEBI:29007

object_name: Diabetic foot infection


subject: CHEBI:29007

object_name: Osteomyelitis of vertebra


subject: CHEBI:29007

object_name: bacterial arthritis


subject: CHEBI:29007

object_name: Infected joint


subject: CHEBI:29007

object_name: osteomyelitis


subject: CHEBI:29007

object_name: abscess


subject: CHEBI:49566

subject_name: Cloxacillin


subject: CHEBI:49566


subject: CHEBI:49566


subject: CHEBI:49566


subject: CHEBI:49566


subject: CHEBI:49566


subject: CHEBI:49566


subject: CHEBI:49566


subject: CHEBI:49566


subject: CHEBI:474053

subject_name: Cefazolin


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:600103

subject_name: daptomycin


subject: CHEBI:600103


subject: CHEBI:600103


subject: CHEBI:600103


subject: CHEBI:600103


subject: CHEBI:600103


subject: CHEBI:600103


subject: CHEBI:600103


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Latent Iron Deficiency


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: Fatty Liver


subject: CHEBI:17347

subject_name: Testosterone


subject: UMLS:C3252015

object_name: Crohn disease


subject: CHEBI:32181

subject_name: Tamibarotene


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Urinary tract problem


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: periventricular leukomalacia


subject: UMLS:C3540792

object_name: Periventricular Leukomalacia, AE


subject: UMLS:C3540792

object_name: Premature birth


subject: UMLS:C3540792

object_name: brain ischemia


subject: UMLS:C3540792

object_name: Intracranial hemorrhage


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: diarrhea


subject: CHEBI:3311

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:3311

object_name: Diarrhea, CTCAE


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:63577


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: UMLS:C0919075


subject: UMLS:C0919075


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: CHEBI:10110


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496


subject: CHEBI:94265

subject_name: Cerubidin

object_name: Childhood Acute Leukemia


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:95165

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:50131

subject_name: Decitabine


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: adult acute myeloid leukemia with del(5q)


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:31355

subject_name: Carboplatin

object_name: ovarian germ cell tumor


subject: CHEBI:31355

object_name: malignant germ cell tumor of ovary


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:35553

subject_name: Perhexiline

object_name: familial hypertrophic cardiomyopathy


subject: UMLS:C3502775

object_name: Advanced breast cancer


subject: CHEBI:231342

subject_name: ceralasertib


subject: UMLS:C3827158


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: Well adult


subject: MESH:C000608553

object_name: age-related macular degeneration


subject: UMLS:C5237317

subject_name: Therapeutic Cancer Vaccine ATP128

object_name: colorectal cancer


subject: UMLS:C5237317

object_name: colorectal carcinoma


subject: UMLS:C5237317

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5237317

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C5237317

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C5237317

object_name: Rectal cancer stage IV


subject: UMLS:C5237317

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C5237317

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C5237317

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C5237317

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C5237317

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C5237317

object_name: metastatic colorectal cancer


subject: UMLS:C5237317

object_name: colon cancer liver metastasis


subject: UMLS:C5237317

object_name: Marinesco-Sjogren syndrome


subject: UMLS:C5237317

object_name: Microsatellite Stable


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UNII:UU4P8NE7UR


subject: UMLS:C5666912

subject_name: VSV-GP-based Cancer Vaccine VSV-GP128


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: UMLS:C5666912


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Nutritional status


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: GTOPDB:13631

subject_name: revusiran

object_name: familial amyloid neuropathy


subject: GTOPDB:13631

object_name: ATTR Amyloidosis


subject: CHEMBL.COMPOUND:CHEMBL4594492

subject_name: REVUSIRAN


subject: CHEMBL.COMPOUND:CHEMBL4594492


subject: CHEBI:23965

subject_name: estradiol

object_name: Turner syndrome


subject: CHEBI:23965

object_name: primary ovarian failure


subject: CHEBI:23965

object_name: premature menopause


subject: UMLS:C2606889

subject_name: AEGR 733

object_name: hyperlipidemia


subject: UMLS:C2606889

object_name: hyperlipoproteinemia


subject: UMLS:C2606889

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C2606889

object_name: Serum lipids high (finding)


subject: CHEBI:72297

subject_name: Lomitapide


subject: CHEBI:72297


subject: CHEBI:72297


subject: CHEBI:72297


subject: CHEBI:32139

object_name: congenital heart disease


subject: UMLS:C5448047

subject_name: STP 705

object_name: Cicatrix, Hypertrophic


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:90942

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:90942

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:90942

object_name: clear cell renal carcinoma


subject: CHEBI:90942

object_name: renal cell adenocarcinoma


subject: CHEBI:90942

object_name: refractory cytopenia of childhood


subject: CHEBI:90942

object_name: renal cell carcinoma


subject: UMLS:C4704930

subject_name: Neuronox

object_name: Torticollis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Primary bacterial peritonitis


subject: CHEBI:60648

object_name: acute spontaneous bacterial peritonitis


subject: CHEBI:60648

object_name: Cirrhosis


subject: CHEBI:60648

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: neuropathy, small fiber


subject: CHEBI:15927

object_name: primary erythermalgia


subject: CHEBI:6801

subject_name: Metformin

object_name: chronic pancreatitis


subject: CHEMBL.COMPOUND:CHEMBL5314975

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:51036475

subject_name: isuzinaxib

object_name: Acute kidney injury caused by contrast agent


subject: UNII:YP664UDC7T

subject_name: Isuzinaxib


subject: UMLS:C4507843


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: metastatic prostate carcinoma


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:50861

subject_name: Treprostinil

object_name: interstitial lung disease


subject: CHEBI:50861

object_name: interstitial lung disease 1


subject: CHEBI:50861

object_name: interstitial lung disease 2


subject: CHEBI:33283

subject_name: THIAMINE

object_name: Postoperative Vasoplegic Syndrome


subject: CHEBI:33283

object_name: Critical Illness


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:64987

object_name: Vertical Disease Transmission


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: Ocular surface disease


subject: CHEBI:4031

object_name: Ocular Surface Disease, CTCAE


subject: UMLS:C2346822

subject_name: conatumumab

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UMLS:C2346822

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2346822

object_name: Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2346822

object_name: Lymphoma, Low-Grade


subject: UMLS:C2346822

object_name: Low grade (lymphoma grade) (finding)


subject: UMLS:C2346822

object_name: mantle cell lymphoma


subject: UMLS:C2346822

object_name: Hodgkin Disease


subject: UMLS:C2346822

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:544190

object_name: autoimmune thrombocytopenia


subject: PUBCHEM.COMPOUND:544190

object_name: thrombocytopenia due to immune destruction


subject: PUBCHEM.COMPOUND:544190

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:7798

subject_name: Oseltamivir


subject: CHEBI:7798


subject: CHEBI:7798


subject: UMLS:C3177195

object_name: Hay fever


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Neoplasm Metastasis


subject: UNII:4EQZ6YO2HI

object_name: Metastasis


subject: UNII:4EQZ6YO2HI

object_name: Metastatic Lesion


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: prostate carcinoma


subject: CHEBI:7903

object_name: prostate cancer


subject: CHEBI:7903

object_name: Childhood Breast Carcinoma


subject: CHEBI:7903

object_name: breast carcinoma


subject: CHEBI:7903

object_name: breast cancer


subject: CHEBI:7903

object_name: Embolism, Tumor


subject: CHEBI:7903


subject: CHEBI:7903


subject: CHEBI:7903


subject: UMLS:C0392938

subject_name: zoledronate


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: bulimia nervosa


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Airway Remodeling


subject: CHEBI:74705

object_name: Asthmatic pulmonary eosinophilia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:44915

subject_name: Propofol

object_name: bipolar disorder


subject: CHEBI:44915

object_name: schizophrenia


subject: UMLS:C2976005

object_name: Cushing syndrome


subject: UMLS:C2976005

object_name: adrenal gland hyperfunction


subject: CHEBI:25805

subject_name: oxygen atom

object_name: obstructive sleep apnea syndrome


subject: CHEBI:15379

subject_name: Oxygen


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: infectious disease


subject: UMLS:C5446615

subject_name: ALK2 Inhibitor INCB000928


subject: UMLS:C5446615

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:90881

subject_name: Camptosar

object_name: Childhood Neuroblastoma


subject: CHEBI:90881

object_name: neuroblastoma


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Myocardial fibrosis


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: CHEBI:87620

subject_name: EPIESTRIOL

object_name: Vaginal Atrophy


subject: CHEBI:27974

subject_name: Estriol


subject: CHEBI:39465

subject_name: timolol

object_name: Wound healed (finding)


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated

object_name: meningococcal meningitis


subject: UMLS:C5240006

subject_name: Vaccine product containing only acellular Bordetella pertussis antigen (medicinal product)


subject: UMLS:C1815829

subject_name: PAPILLOMAVIRUS HUMAN QUADRIVALENT VACCINE


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: congestive heart failure


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:176795

subject_name: pyridinium chlorochromate

object_name: Post-partum hemorrhage


subject: UNII:03ZI7ZZW5Q


subject: UMLS:C4048712

subject_name: factor IX complex


subject: MESH:C000615293

object_name: Depressed mood


subject: MESH:C000615293

object_name: Cancer patients and suicide and depression


subject: MESH:C000615293

object_name: Depressed - symptom


subject: MESH:C000615293

object_name: Depression, CTCAE


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: T-Cell Lymphoma


subject: UMLS:C1831941


subject: CHEBI:6933

subject_name: Midodrine

object_name: Decompensated cirrhosis of liver


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: pediatric osteosarcoma


subject: UNII:43K1W2T1M6

object_name: Osteosarcoma


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human


subject: UMLS:C1610033


subject: PR:000024938

subject_name: interferon alpha


subject: PR:000024938


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C2825023


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Injury of ureter


subject: UNII:T42P99266K

object_name: Surgical procedure finding


subject: UNII:T42P99266K

object_name: Surgery--Complications


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UNII:N5UK68MGDZ

object_name: vitiligo


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:15927

object_name: amyotrophic lateral sclerosis


subject: UNII:FBS8JQ0T3V

subject_name: Pterostilbene


subject: UNII:FBS8JQ0T3V


subject: CHEBI:95129

subject_name: cisapride

object_name: diabetes mellitus


subject: CHEBI:2038

subject_name: Azacitidine

object_name: FLT3 Activation Loop Mutation


subject: CHEBI:2038

object_name: FLT3 Internal Tandem Duplication


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:145372

object_name: Refractory acute myeloid leukemia


subject: CHEBI:145372


subject: CHEBI:145372


subject: PUBCHEM.COMPOUND:71300864

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:71300864

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UMLS:C2933615


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril


subject: PUBCHEM.COMPOUND:54214995


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: CHEBI:71464

subject_name: Palmidrol

object_name: migraine


subject: CHEBI:71464

object_name: Transformed migraine


subject: CHEBI:71464

object_name: Episodic migraine


subject: CHEBI:92511

subject_name: Ketotifen

object_name: liver disorder


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: hepatosplenic T-cell lymphoma


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: Early syphilis, unspecified


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:17334

subject_name: penicillin


subject: RXCUI:605343

subject_name: Synera

object_name: elbow epicondylitis


subject: CHEBI:40279

subject_name: Allopurinol

object_name: IgA Nephropathy


subject: PUBCHEM.COMPOUND:2269

object_name: syphilis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: Stomach cancer


subject: UMLS:C0599934

object_name: gastric cancer


subject: UMLS:C3896672

subject_name: Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine

object_name: FIGO Stage III Ovarian Cancer 2014


subject: UMLS:C3896672

object_name: FIGO Stage IV Ovarian Cancer 2014


subject: UMLS:C3896672

object_name: Advanced Primary Peritoneal Carcinoma


subject: UMLS:C3896672

object_name: Advanced Fallopian Tube Carcinoma


subject: UMLS:C3896672

object_name: Advanced Ovarian Carcinoma


subject: UMLS:C3896672

object_name: Clear cell adenocarcinoma of peritoneum


subject: UMLS:C3896672

object_name: Advanced Ovarian Carcinosarcoma


subject: UMLS:C3896672

object_name: Advanced Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UMLS:C3896672

object_name: Ovarian Mixed Cell Adenocarcinoma


subject: UMLS:C3896672

object_name: Advanced Fallopian Tube High Grade Serous Adenocarcinoma


subject: UMLS:C3896672

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: UMLS:C3896672

object_name: Advanced Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C3896672

object_name: Advanced Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C3896672

object_name: fallopian tube endometrioid adenocarcinoma


subject: UMLS:C3896672

object_name: Advanced Ovarian Endometrioid Adenocarcinoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Angiectasis


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088

object_name: anemia


subject: CHEBI:36088

object_name: Anemia, CTCAE


subject: UMLS:C5449141

subject_name: Propofol Injectable Emulsion

object_name: insomnia


subject: UMLS:C5449141

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C5449141

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C5449141

object_name: sleep disorder


subject: UMLS:C5449141

object_name: Dyssomnias


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:66964

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: adult papillary meningioma


subject: UNII:2S9ZZM9Q9V

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage I squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage I inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage I midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: Salivary gland cancer stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Salivary gland cancer stage I


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Salivary gland cancer stage IV


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: UNII:2S9ZZM9Q9V

object_name: Oropharyngeal lymphoepithelioma stage I


subject: UNII:2S9ZZM9Q9V

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:2S9ZZM9Q9V

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UNII:2S9ZZM9Q9V

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:2S9ZZM9Q9V

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UNII:2S9ZZM9Q9V

object_name: Laryngeal squamous cell carcinoma stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UNII:2S9ZZM9Q9V

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Laryngeal verrucous carcinoma stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Lip Basal Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: UNII:2S9ZZM9Q9V

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: UNII:2S9ZZM9Q9V

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: UNII:2S9ZZM9Q9V

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Verrucous carcinoma of the oral cavity stage I


subject: UNII:2S9ZZM9Q9V

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: UNII:2S9ZZM9Q9V

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: UNII:2S9ZZM9Q9V

object_name: Laryngeal squamous cell carcinoma stage I


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Laryngeal verrucous carcinoma stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Lip Basal Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Laryngeal verrucous carcinoma stage I


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Lip Basal Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Lip Basal Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: adult central nervous system germ cell tumor


subject: UNII:2S9ZZM9Q9V

object_name: adult choroid plexus neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: meningeal melanocytoma


subject: UNII:2S9ZZM9Q9V

object_name: meningeal melanocytoma, adult


subject: UNII:2S9ZZM9Q9V

object_name: Adult Anaplastic Oligodendroglioma


subject: UNII:2S9ZZM9Q9V

object_name: adult malignant hemangiopericytoma


subject: UNII:2S9ZZM9Q9V

object_name: adult anaplastic ependymoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Diffuse Astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Mixed Glioma


subject: UNII:2S9ZZM9Q9V

object_name: Primary malignant neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Malignant obstetric neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Adult Pineocytoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Ependymoma


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: Hypercholesterolemia


subject: UniProtKB:P19726

object_name: hypertension


subject: UniProtKB:P19726

object_name: Hypertension, CTCAE


subject: UMLS:C1971343

subject_name: Injection, ranibizumab, 0.1 mg administered

object_name: diabetic retinopathy


subject: UNII:1693AM5SBN

subject_name: Salvia miltiorrhiza root

object_name: Angina pectoris


subject: CHEBI:228939


subject: CHEBI:228939

object_name: Inflammation


subject: PUBCHEM.COMPOUND:105118

subject_name: Methylenetanshinquinone


subject: PUBCHEM.COMPOUND:105118


subject: PUBCHEM.COMPOUND:78210288

object_name: diabetes mellitus


subject: UNII:VZ3FG834W3


subject: CHEBI:64317

subject_name: Isoprenaline

object_name: Vasodilation disorder


subject: CHEBI:64317

object_name: Pathologic vasoconstriction


subject: CHEBI:64317

object_name: Vasoconstriction


subject: PUBCHEM.COMPOUND:11957447

subject_name: NOREPINEPHRINE BITARTRATE


subject: PUBCHEM.COMPOUND:11957447


subject: PUBCHEM.COMPOUND:11957447


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:17026

subject_name: Progesterone

object_name: preeclampsia


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: persistent atrial fibrillation


subject: UMLS:C5555594

subject_name: Lutetium Lu-177 PNT2002

object_name: Adenocarcinoma of the prostate recurrent


subject: UMLS:C5555594

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C5555594

object_name: Oligometastatic Prostate Carcinoma


subject: UMLS:C5555594

object_name: prostate adenocarcinoma


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Prolonged grief disorder


subject: MESH:D002214

subject_name: Capsules

object_name: Psychiatric problem


subject: MESH:D002214

object_name: Cognitive impairment


subject: MESH:D002214

object_name: Perceptual disturbance


subject: CHEBI:176510

object_name: Childhood Neuroblastoma


subject: CHEBI:176510

object_name: neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL1609891

subject_name: BUTHIONINE SULFOXIMINE


subject: CHEMBL.COMPOUND:CHEMBL1609891


subject: UMLS:C0054252

subject_name: Buthionine Sulfoximine


subject: UMLS:C0054252


subject: CHEBI:9434

subject_name: Telmisartan

object_name: myocardial ischemia


subject: CHEBI:9434

object_name: acute myocardial infarction


subject: CHEBI:9434

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:9434

object_name: acute coronary syndrome


subject: CHEBI:9434

object_name: Angina pectoris


subject: PUBCHEM.COMPOUND:16170201

subject_name: TEICOPLANIN

object_name: lumbar spinal stenosis


subject: PUBCHEM.COMPOUND:16170201

object_name: spinal stenosis


subject: PUBCHEM.COMPOUND:16170201

object_name: Lumbar spondylolisthesis


subject: PUBCHEM.COMPOUND:16170201

object_name: Lumbar scoliosis


subject: PUBCHEM.COMPOUND:16170201

object_name: lumbar disc herniation


subject: PUBCHEM.COMPOUND:16170201

object_name: Lumbar disc lesion


subject: GTOPDB:9297

subject_name: lutikizumab

object_name: Crohn disease


subject: CHEMBL.COMPOUND:CHEMBL4594518

subject_name: LUTIKIZUMAB


subject: UMLS:C5226856


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Diabetes mellitus without mention of complication


subject: CHEBI:77733

subject_name: Verapamil

object_name: peripheral; vasospasm


subject: CHEBI:77733

object_name: Burning Sensation


subject: UMLS:C0949110

subject_name: Aluminum hydroxide oral suspension BP


subject: UMLS:C1134664


subject: UMLS:C1176324

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Complication of perfusion


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: Nocturia


subject: CHEBI:31596

subject_name: Febuxostat

object_name: Increased reactive oxygen species production


subject: CHEBI:31596

object_name: Cardiovascular System Finding


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED

object_name: hypertension


subject: UMLS:C1314420

object_name: Hypertension, CTCAE


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: esophageal squamous cell carcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Ischemic stroke


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: osteoporosis


subject: CHEBI:31186

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:31186

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:31186

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Anastomotic Leak


subject: CHEBI:100241

object_name: rectal carcinoma


subject: CHEBI:100241

object_name: rectal cancer


subject: CHEBI:100241

object_name: Childhood Rectal Carcinoma


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: PR:000007515

subject_name: four and a half LIM domains protein 5

object_name: Stomach cancer


subject: PR:000007515

object_name: gastric cancer


subject: PR:000014683


subject: PR:000014683


subject: PR:000023516

subject_name: pyruvate formate-lyase 1-activating enzyme


subject: PR:000023516


subject: UniProtKB:P0A9N4

subject_name: PFLA_ECOLI Pyruvate formate-lyase 1-activating enzyme (sprot)


subject: UniProtKB:P0A9N4


subject: CHEBI:84415

subject_name: acetyltaurine


subject: CHEBI:84415


subject: PR:000014937

subject_name: Na(+)/citrate cotransporter


subject: PR:000014937


subject: UNII:5G1WE425BI

subject_name: Rilzabrutinib

object_name: autoimmune hemolytic anemia


subject: UNII:NWN58M4F5T

subject_name: RILZABRUTINIB


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Large adenoids


subject: UMLS:C0360094

object_name: Enlarged tonsils


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: post operative nausea and vomiting


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Throat cancer


subject: UNII:M89N0Q7EQR

object_name: Human Papillomavirus-Related Vaginal Adenocarcinoma


subject: UNII:M89N0Q7EQR

object_name: HPV positive rectal squamous cell carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Birth Injuries


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:34967

subject_name: Rimonabant

object_name: Weight loss


subject: CHEBI:34967

object_name: Weight Loss, CTCAE


subject: UMLS:C1174273


subject: UMLS:C1174273


subject: UMLS:C3889729

subject_name: Carbon Nanoparticle-based Formulation

object_name: thyroid tumor


subject: UMLS:C3889729

object_name: thyroid gland carcinoma


subject: UMLS:C3889729

object_name: thyroid cancer


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: Severe hereditary factor VIII deficiency disease without inhibitor


subject: UNII:7NL2E3F6K3

object_name: hemarthrosis


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Post-traumatic endophthalmitis


subject: CHEBI:63611

object_name: Open globe injury


subject: CHEBI:59527

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: UMLS:C5241873

subject_name: peanut protein

object_name: food allergy


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: peripheral nerve injury


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:33704

subject_name: Amino acid

object_name: acute kidney failure


subject: CHEBI:33704

object_name: Acute Kidney Injury, CTCAE


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: sleep apnea


subject: UMLS:C0002521

object_name: Sleep Apnea, CTCAE


subject: CHEBI:26708

subject_name: sodium atom

object_name: hypothyroidism


subject: CHEBI:26708

object_name: Hypothyroidism, CTCAE


subject: CHEBI:29101

subject_name: Sodium cation


subject: CHEBI:29101


subject: UMLS:C3541959

subject_name: Sodium supplements


subject: UMLS:C3541959


subject: UMLS:C3714642

subject_name: Sodium Drug Class


subject: UMLS:C3714642


subject: PUBCHEM.COMPOUND:6420057

subject_name: METOPROLOL TARTRATE

object_name: heart disorder


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:63791

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:63791

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:63791

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:63791

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:63791

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:63791

object_name: myelodysplastic syndrome with multilineage dysplasia


subject: CHEBI:63791

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:8F5X4B082E

subject_name: Lixivaptan

object_name: Hyponatremia


subject: UNII:8F5X4B082E

object_name: Hyponatremia, CTCAE


subject: UMLS:C1870424

object_name: malignant pleural mesothelioma


subject: CHEBI:8871

subject_name: Risperidone

object_name: Anorexia


subject: PUBCHEM.COMPOUND:131729795

subject_name: Carboplatin Paclitaxel

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:131729795

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:131729795

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:131729795

object_name: neoplasm of esophagus


subject: CHEBI:73275

subject_name: Ospemifene

object_name: Atrophic


subject: CHEBI:73275

object_name: vaginal disease


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: Stage III Colon Cancer


subject: CHEBI:6432

subject_name: Levamisole


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UNII:8G388563M7

subject_name: Telotristat ethyl

object_name: Metastatic Neuroendocrine Neoplasm


subject: UNII:8G388563M7

object_name: Locally Advanced Neuroendocrine Neoplasm


subject: CHEBI:4471

subject_name: dextromethorphan hydrobromide

object_name: common cold


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:6520

subject_name: Lomustine

object_name: central nervous system neoplasm


subject: CHEBI:6520

object_name: central nervous system cancer


subject: CHEBI:9168

subject_name: Sirolimus

object_name: dilated cardiomyopathy


subject: CHEBI:9168

object_name: Kaposi's sarcoma-associated human herpesvirus infection


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: fibromatosis


subject: CHEBI:45863

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: CHEBI:45863

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Vascular System Injuries


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: salivary gland disorder


subject: PUBCHEM.COMPOUND:134506

object_name: Epiphora


subject: PUBCHEM.COMPOUND:134506

object_name: lacrimal apparatus disorder


subject: PUBCHEM.COMPOUND:134506

object_name: Xerostomia


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: UNII:C8385V1KQ6

object_name: human papilloma virus infection


subject: PUBCHEM.COMPOUND:78210288

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:78210288

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:78210288

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:78210288

object_name: pulmonary arterial hypertension


subject: UNII:VZ3FG834W3


subject: UNII:VZ3FG834W3


subject: UNII:VZ3FG834W3


subject: UNII:VZ3FG834W3


subject: CHEBI:261649

subject_name: Bismuth subsalicylate

object_name: Nonulcer dyspepsia


subject: CHEBI:261649

object_name: Peptic Ulcer


subject: CHEBI:85545

subject_name: Bismuth cation


subject: CHEBI:85545


subject: CHEBI:33301

subject_name: bismuth atom


subject: CHEBI:33301


subject: UMLS:C2917658

subject_name: Bismuth [EPC]


subject: UMLS:C2917658


subject: CHEBI:134689

subject_name: Rucaparib

object_name: Carcinoma breast stage IV


subject: UMLS:C5555802

subject_name: Anti-TREM2 Monoclonal Antibody PY314

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5555802

object_name: hormone receptor/growth factor receptor-negative breast cancer


subject: UMLS:C5555802

object_name: triple-negative breast carcinoma


subject: UMLS:C5555802

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5555802

object_name: colorectal cancer


subject: UMLS:C5555802

object_name: colorectal carcinoma


subject: UMLS:C5555802

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5555802

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5555802

object_name: clear cell renal carcinoma


subject: UMLS:C5555802

object_name: renal cell adenocarcinoma


subject: UMLS:C5555802

object_name: renal cell carcinoma


subject: UMLS:C5555802

object_name: female reproductive organ cancer


subject: UMLS:C5555802

object_name: lung adenocarcinoma


subject: UMLS:C5555802

object_name: ovarian cancer


subject: UMLS:C5555802

object_name: ovarian neoplasm


subject: UMLS:C5555802

object_name: ovarian carcinoma


subject: UMLS:C5555802

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555802

object_name: breast carcinoma


subject: UMLS:C5555802

object_name: breast cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: hormone receptor/growth factor receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:24868177

subject_name: neuropeptide Y

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:24868177

object_name: obesity


subject: PUBCHEM.COMPOUND:24868177

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:24868177

object_name: hypertension


subject: PUBCHEM.COMPOUND:24868177

object_name: Hypertension, CTCAE


subject: CHEBI:80201

subject_name: Neuropeptide Y


subject: CHEBI:80201


subject: CHEBI:80201


subject: CHEBI:80201


subject: CHEBI:80201


subject: PR:000011387


subject: PR:000011387


subject: PR:000011387


subject: PR:000011387


subject: PR:000011387


subject: PUBCHEM.COMPOUND:24984318

subject_name: Valbenazine

object_name: Huntington disease


subject: CHEBI:60654

subject_name: valproate

object_name: Status epilepticus


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:2285XW22DR

object_name: stage IV pancreatic cancer


subject: UNII:2285XW22DR

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)

object_name: Autoimmunity


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: female infertility


subject: PUBCHEM.COMPOUND:4622926

subject_name: Epothilone D

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:4622926

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:4622926

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Childhood Breast Carcinoma


subject: UMLS:C3714501

object_name: breast carcinoma


subject: UMLS:C3714501

object_name: breast cancer


subject: UMLS:C3714501

object_name: insulin sensitivity/resistance


subject: UMLS:C3714501

object_name: survival time


subject: UMLS:C3714501

object_name: metabolic disturbance


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:75998

subject_name: Trametinib

object_name: Acute lymphoblastic leukemia, in relapse


subject: CHEBI:75998

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:75998

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) refractory


subject: CHEBI:75998

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) refractory


subject: CHEBI:75998

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) recurrent


subject: CHEBI:75998

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) recurrent


subject: MESH:D007252

subject_name: Influenza Vaccines

object_name: Inflammation


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Dyssomnias


subject: CHEBI:46195

object_name: Sleep abnormality


subject: CHEBI:46195

object_name: sleep disorder


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659

object_name: Pregnant


subject: UMLS:C2917659


subject: CHEBI:52717

subject_name: Bortezomib

object_name: bronchiolitis obliterans syndrome


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: hip pain chronic


subject: UMLS:C0592557

subject_name: Ametop

object_name: Cognitive changes


subject: CHEBI:9468

subject_name: Tetracaine


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Small cell lung cancer extensive stage


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:53760


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Intracranial Atherosclerosis


subject: CHEBI:38545

object_name: stroke disorder


subject: CHEBI:38545

object_name: Stroke (heart beat)


subject: CHEBI:38545

object_name: Stroke, CTCAE


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: neoplasm


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Clozapine poisoning


subject: CHEMBL.COMPOUND:CHEMBL2146146

subject_name: ATROPINE SULFATE

object_name: Myopia, Progressive


subject: UNII:03J5ZE7KA5


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:79699

object_name: Plexosarcoma


subject: CHEBI:79699

object_name: stage I adult soft tissue sarcoma


subject: CHEBI:79699

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:79699

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:79699

object_name: stage II adult soft tissue sarcoma


subject: UMLS:C4727626

subject_name: MVA-BN-brachyury-TRICOM vaccine

object_name: Metastatic Malignant Solid Neoplasm


subject: PR:000029672

subject_name: phosphate-regulating neutral endopeptidase PHEX

object_name: interstitial lung disease 2


subject: PR:000029672

object_name: pulmonary fibrosis


subject: PR:000029672

object_name: idiopathic interstitial pneumonia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:164933665

subject_name: enlicitide

object_name: kidney failure


subject: UNII:R7EZ772VG2

subject_name: ENLICITIDE


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: Ischemic stroke


subject: PR:000006592


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: end stage renal failure


subject: CHEBI:3311

object_name: Chronic uremia


subject: UMLS:C5418025

subject_name: Anti-IRF4 ASO ION251

object_name: Plasma cell myeloma refractory


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Prosthetic joint infection


subject: UMLS:C0555881

subject_name: Arnica extract

object_name: Acute Pain


subject: UMLS:C0555881

object_name: Myalgia


subject: DRUGBANK:DB14343

subject_name: Arnica montana flower


subject: DRUGBANK:DB14343


subject: UMLS:C1146478

subject_name: Arnica mollis, flower essences


subject: UMLS:C1146478


subject: CHEBI:474053

object_name: endophthalmitis


subject: CHEBI:474053

object_name: Endophthalmitis, CTCAE


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: UNII:2AW48LAZ4I

subject_name: IMETELSTAT SODIUM

object_name: Recurrent tumors of the Ewing's family


subject: UNII:2AW48LAZ4I

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:2AW48LAZ4I

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: UNII:2AW48LAZ4I

object_name: Recurrent Childhood Liver Cancer


subject: UNII:2AW48LAZ4I

object_name: Neuroblastoma recurrent


subject: UNII:2AW48LAZ4I

object_name: Osteosarcoma recurrent


subject: UNII:2AW48LAZ4I

object_name: Adult Rhabdomyosarcoma


subject: UNII:2AW48LAZ4I

object_name: rhabdomyosarcoma


subject: UNII:2AW48LAZ4I

object_name: Childhood Rhabdomyosarcoma


subject: UNII:2AW48LAZ4I

object_name: hepatoblastoma


subject: UNII:2AW48LAZ4I

object_name: liver carcinoma


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:74T7185BMM

subject_name: Inebilizumab

object_name: Immunoglobulin G4-Related Disease


subject: UMLS:C2981806


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: cognitive disorder


subject: CHEBI:31236

object_name: Primary demyelination


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: malignant glioma


subject: CHEBI:82677

object_name: glioblastoma


subject: CHEBI:82677

object_name: Childhood Glioblastoma


subject: CHEBI:82677

object_name: adult glioblastoma


subject: CHEBI:82677

object_name: Adult Gliosarcoma


subject: CHEBI:82677

object_name: gliosarcoma


subject: CHEBI:82677

object_name: Childhood Gliosarcoma


subject: UMLS:C1873068


subject: UMLS:C1873068


subject: UMLS:C1873068


subject: UMLS:C1873068


subject: UMLS:C1873068


subject: UMLS:C1873068


subject: UMLS:C1873068


subject: CHEBI:50858

subject_name: corticosteroid

object_name: systemic inflammatory response syndrome


subject: CHEBI:50858

object_name: heart valve disorder


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UMLS:C2717339

object_name: irritable bowel syndrome


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine

object_name: Lobar Pneumonia


subject: UMLS:C0305065

object_name: streptococcal pneumonia


subject: UMLS:C1579319

subject_name: pneumococcal conjugate vaccine


subject: UMLS:C1579319


subject: UMLS:C0993938

subject_name: Injection, ciprofloxacin for intravenous infusion, 200 mg

object_name: Infection


subject: UMLS:C0993938

object_name: infectious disease


subject: UMLS:C0993938

object_name: Adverse Event Associated with Infection


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: type 2 diabetes mellitus


subject: UMLS:C0885467

object_name: Insulin resistance


subject: UMLS:C0885467

object_name: Androgen excess


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: melanoma


subject: CHEBI:39548

object_name: immune-mediated adverse reaction


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17650

object_name: obesity


subject: CHEBI:17650

object_name: Obesity, CTCAE


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Hypoglycaemic episode


subject: CHEBI:85078

object_name: Recurrent hypoglycemia


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: Shingles, CTCAE


subject: UMLS:C5854493

subject_name: Anti-nectin-4 Antibody-drug Conjugate SHR-A2102

object_name: Solid Neoplasm


subject: UMLS:C5785368

subject_name: KRAS G12D Inhibitor HRS-4642


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: cystic fibrosis


subject: UMLS:C0972319

subject_name: BIIL 284

object_name: COPD, severe early onset


subject: UMLS:C0972319

object_name: chronic obstructive pulmonary disease


subject: CHEBI:4670

subject_name: Dobutamine

object_name: septic shock


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: Plexosarcoma


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46

object_name: cancer of unknown primary site


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: precancerous condition


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: HER2 positive breast carcinoma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: IDH-wildtype glioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: astrocytoma, IDH-mutant, grade 2


subject: UNII:2S9ZZM9Q9V

object_name: Microsatellite instability-high solid malignant tumor


subject: UNII:2S9ZZM9Q9V

object_name: trabecular adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: CHEBI:31355


subject: CHEBI:31355

object_name: Microsatellite instability-high colorectal cancer


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679

object_name: esophageal squamous cell carcinoma


subject: CHEBI:231679

object_name: squamous cell carcinoma


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646

object_name: head and neck squamous cell carcinoma


subject: CHEBI:68646


subject: CHEBI:68646

object_name: non-small cell lung carcinoma


subject: CHEBI:68646

object_name: cervical cancer


subject: CHEBI:68646

object_name: cervical carcinoma


subject: CHEBI:68646


subject: CHEBI:68646

object_name: urothelial carcinoma


subject: CHEBI:68646

object_name: transitional cell carcinoma


subject: CHEBI:68646

object_name: small cell lung carcinoma


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:68646

object_name: clear cell renal carcinoma


subject: CHEBI:68646

object_name: renal cell adenocarcinoma


subject: CHEBI:68646

object_name: carcinoma of esophagus


subject: CHEBI:68646

object_name: esophageal cancer


subject: CHEBI:68646

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:68646

object_name: Stomach cancer


subject: CHEBI:68646

object_name: gastric cancer


subject: CHEBI:68647

subject_name: Regorafenib

object_name: astrocytoma, IDH-mutant, grade 2


subject: CHEBI:68647

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: CHEBI:68647

object_name: Microsatellite instability-high solid malignant tumor


subject: CHEBI:68647

object_name: head and neck squamous cell carcinoma


subject: CHEBI:68647

object_name: esophageal squamous cell carcinoma


subject: CHEBI:68647

object_name: non-small cell lung carcinoma


subject: CHEBI:68647

object_name: cervical cancer


subject: CHEBI:68647

object_name: cervical carcinoma


subject: CHEBI:68647

object_name: squamous cell carcinoma


subject: CHEBI:68647

object_name: urothelial carcinoma


subject: CHEBI:68647

object_name: transitional cell carcinoma


subject: CHEBI:68647

object_name: small cell lung carcinoma


subject: CHEBI:68647

object_name: trabecular adenocarcinoma


subject: CHEBI:68647

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:68647

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:68647

object_name: clear cell renal carcinoma


subject: CHEBI:68647

object_name: renal cell adenocarcinoma


subject: CHEBI:68647

object_name: carcinoma of esophagus


subject: CHEBI:68647

object_name: esophageal cancer


subject: CHEBI:68647

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:68647

object_name: Stomach cancer


subject: CHEBI:68647

object_name: gastric cancer


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: UMLS:C0009873

subject_name: Contraceptive Agents, Female

object_name: Uses contraception (finding)


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: inherited hemoglobinopathy


subject: CHEBI:4026

object_name: hemoglobinopathy


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:36467

subject_name: Ciguatoxins


subject: CHEBI:36467


subject: CHEBI:36467

object_name: sickle cell disease


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: CHEBI:204928


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C5574748


subject: UMLS:C5574748


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UMLS:C0010377


subject: UMLS:C0010377


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UniProtKB:P41416


subject: UniProtKB:P41416


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: colorectal adenoma


subject: CHEBI:30021

subject_name: Selenomethionine


subject: CHEBI:90227

subject_name: Selumetinib

object_name: NF2-related schwannomatosis


subject: CHEBI:90227

object_name: vestibular schwannomatosis


subject: CHEBI:90227

object_name: acoustic neuroma


subject: CHEBI:90227

object_name: Adult Meningioma


subject: CHEBI:90227

object_name: benign meningioma


subject: CHEBI:90227

object_name: familial meningioma


subject: CHEBI:90227

object_name: pediatric meningioma


subject: CHEBI:90227

object_name: meningioma


subject: CHEBI:90227

object_name: glioma susceptibility 1


subject: CHEBI:90227

object_name: ependymoma


subject: CHEBI:90227

object_name: childhood ependymoma


subject: CHEBI:90227

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:90227

object_name: Adult Ependymoma


subject: CHEBI:90227

object_name: glioma


subject: CHEBI:90227

object_name: malignant glioma


subject: CHEBI:75551

object_name: progressive supranuclear palsy


subject: CHEBI:94708

subject_name: Diacerein

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: rosacea


subject: CHEBI:47499

subject_name: Imipramine


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: digestive system cancer


subject: UMLS:C4527158


subject: UMLS:C4508238

object_name: hepatitis C


subject: CHEBI:17632

subject_name: Nitrate

object_name: Coronaropathy


subject: CHEBI:6061

subject_name: Isosorbide dinitrate


subject: CHEBI:28787

subject_name: Nitroglycerin


subject: CHEBI:31772

object_name: Laceration of vagina


subject: UMLS:C0875986

subject_name: Chirocaine


subject: CHEBI:6149

subject_name: Levobupivacaine


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: pancreatic neoplasm


subject: CHEBI:79699

object_name: exocrine pancreatic carcinoma


subject: CHEBI:79699

object_name: malignant pancreatic neoplasm


subject: CHEBI:79699

object_name: non-small cell lung carcinoma


subject: CHEBI:79699

object_name: colorectal carcinoma


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: chikungunya


subject: UMLS:C5203461

subject_name: Paricalcitol Liquid Injection

object_name: autosomal dominant hypocalcemia


subject: UMLS:C5203461

object_name: Hypocalcemia


subject: UMLS:C5203461

object_name: Serum calcium below normal (finding)


subject: UMLS:C5203461

object_name: Hypocalcemia, CTCAE


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:125400

subject_name: actinomycin D

object_name: rhabdomyosarcoma


subject: CHEBI:125400

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:125400

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:90881

subject_name: Camptosar

object_name: spindle cell rhabdomyosarcoma


subject: CHEBI:90881

object_name: embryonal rhabdomyosarcoma


subject: CHEBI:90881

object_name: botryoid rhabdomyosarcoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699

object_name: Childhood Embryonal Rhabdomyosarcoma


subject: CHEBI:79699

object_name: childhood botryoid rhabdomyosarcoma


subject: CHEBI:79699


subject: UMLS:C5574906

subject_name: Epidermal growth factor receptor inhibitor

object_name: Advanced cancer


subject: UNII:V5Y646AW8S

object_name: treatment resistant depression


subject: UNII:V5Y646AW8S


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:182913

subject_name: Dexpramipexole


subject: CHEBI:182913


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Pancreatic adenocarcinoma resectable


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:6KA1906BLC

subject_name: pinatuzumab vedotin

object_name: diffuse large B-cell lymphoma


subject: UNII:6KA1906BLC

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:6KA1906BLC

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:6KA1906BLC

object_name: follicular lymphoma


subject: UMLS:C3641731


subject: UMLS:C3641731


subject: UMLS:C3641731


subject: UMLS:C3641731


subject: CHEBI:3219

subject_name: Bupropion

object_name: sleep disorder


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch


subject: GTOPDB:12347

subject_name: penpulimab

object_name: primary central nervous system lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:27732

subject_name: Caffeine

object_name: c.surgical procedure; digestive system


subject: UMLS:C5907940

subject_name: Anti-mutant Calreticulin Monoclonal Antibody INCA033989

object_name: myeloproliferative neoplasm


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Pain of temporomandibular joint


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UNII:E8I3O45DDU

object_name: Increased reactive oxygen species production


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:234248D0HH

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:95341

subject_name: Baricitinib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:95341

object_name: acute myeloid leukemia


subject: CHEBI:95341

object_name: Myelodysplasia


subject: CHEBI:95341

object_name: acute lymphoblastic leukemia


subject: CHEBI:95341

object_name: acute biphenotypic leukemia


subject: CHEBI:95341

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:95341

object_name: lymphoma


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Carcinoma breast stage IV


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:124959

subject_name: Tilarginine

object_name: Irritable heart


subject: CHEBI:124959

object_name: Vasovagal syncope


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:8093

subject_name: Phenylephrine


subject: UMLS:C2348275

subject_name: Dietary Nitrate

object_name: gingivitis


subject: UMLS:C2348275

object_name: Gingival bleeding


subject: UMLS:C2348275

object_name: gingival disorder


subject: UMLS:C2348275

object_name: periodontal disorder


subject: UMLS:C2348275

object_name: cardiovascular disorder


subject: UMLS:C2825028

subject_name: Insulin Analog [EPC]

object_name: hyperglycemia


subject: UMLS:C2825028

object_name: Hyperglycemia, CTCAE


subject: UMLS:C2825028

object_name: Glucose in blood specimen above reference range


subject: UMLS:C2825028

object_name: Acute Stroke


subject: GTOPDB:13455

subject_name: felzartamab

object_name: lupus nephritis


subject: UNII:3O9FA4XC02


subject: UMLS:C3273720


subject: CHEBI:18361

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: Episodic migraine


subject: DRUGBANK:DB10510

subject_name: Brazil nut

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB10510

object_name: obesity


subject: DRUGBANK:DB10510

object_name: Obesity, CTCAE


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: Inflammation


subject: DRUGBANK:DB05418

object_name: sleep disorder


subject: UMLS:C4058555

subject_name: Spiriva Respimat

object_name: asthma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: peripheral nervous system disorder


subject: CHEBI:3215

object_name: Local anaesthetic systemic toxicity


subject: CHEBI:3215

object_name: Intraoperative hypotension


subject: CHEBI:3215

object_name: Intraoperative hypertension


subject: CHEBI:3215

object_name: Arm Fracture


subject: CHEBI:3215

object_name: Fracture of the lower limb (except hip), initial encounter


subject: CHEBI:3215

object_name: Pain Disorder


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918

object_name: neuropathy


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Cognitive impairment


subject: UMLS:C4329336

object_name: plasma cell myeloma


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Acute asthma


subject: UMLS:C5206857

subject_name: 5-HT4 Agonist TAK-954

object_name: Hepatic impairment


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: benign neoplasm of pancreas


subject: UMLS:C3854029

object_name: pancreatic mucinous cystadenoma


subject: UMLS:C3854029

object_name: pancreatic mucinous cystadenocarcinoma


subject: UMLS:C3854029

object_name: mucinous cystic neoplasm with moderate dysplasia


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: UMLS:C5201230

subject_name: Paclitaxel Liquid Injection


subject: UMLS:C5201230


subject: UMLS:C5201230


subject: UMLS:C5201230


subject: UMLS:C3854151

subject_name: Injection, paclitaxel, 1 mg administered


subject: UMLS:C3854151


subject: UMLS:C3854151


subject: UMLS:C3854151


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Burn injury


subject: UMLS:C3714803

object_name: Burn, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:8774

subject_name: Ramipril

object_name: Albuminuria


subject: CHEBI:5959

subject_name: Irbesartan


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:47458

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:47458

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:47458

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:47458

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:47458

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:47458

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:47458

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:47458

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:47458

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:47458

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:47458

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:47458

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:47458

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:47458

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:47458

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:47458

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:47458

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:47458

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:47458

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:47458

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:47458

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:47458

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:47458

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:47458

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:47458

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:47458

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:47458

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:47458

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:47458

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:47458

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:47458

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:47458

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:47458

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:47458

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:47458

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:47458

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:47458

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:47458

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:47458

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:47458

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:47458

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:47458

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:47458

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:47458

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:47458

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:47458

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:47458

object_name: tongue cancer


subject: CHEBI:47458

object_name: tongue carcinoma


subject: CHEBI:47458

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:47458

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:47458

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UMLS:C0051560

subject_name: Amelogenin

object_name: Periodontal Attachment Loss


subject: UMLS:C0051560

object_name: Impacted tooth


subject: UMLS:C5555083

subject_name: Microbiota-based Formulation RBX7455

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: triple-negative breast carcinoma


subject: UMLS:C5555083

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C5555083

object_name: invasive breast carcinoma


subject: UMLS:C5555083

object_name: breast adenocarcinoma


subject: CHEBI:36791

subject_name: Escitalopram

object_name: phobic disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: PUBCHEM.COMPOUND:18375622

subject_name: MART-1 Antigen

object_name: skin melanoma


subject: UMLS:C3146272

subject_name: MART-1 Antigen (vaccine component)


subject: UMLS:C1510427

subject_name: Recombinant MAGE-3.1 Antigen


subject: UMLS:C1328728


subject: CHEBI:18394

subject_name: Palatinose

object_name: Overweight and obesity


subject: UNII:V59P50X4UY

subject_name: isomaltulose


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: conduct disorder


subject: CHEBI:25681

object_name: oppositional defiant disorder


subject: PUBCHEM.COMPOUND:2781

subject_name: Meclastine

object_name: relapsing-remitting multiple sclerosis


subject: PUBCHEM.COMPOUND:2781

object_name: Multiple sclerosis relapse


subject: PUBCHEM.COMPOUND:2781

object_name: Benign multiple sclerosis


subject: PUBCHEM.COMPOUND:2781

object_name: chronic progressive multiple sclerosis


subject: PUBCHEM.COMPOUND:2781

object_name: primary progressive multiple sclerosis


subject: CHEBI:3738

subject_name: Clemastine


subject: CHEBI:3738


subject: CHEBI:3738


subject: CHEBI:3738


subject: CHEBI:3738


subject: UMLS:C2699335

subject_name: cixutumumab

object_name: Neck Carcinoma


subject: UMLS:C2699335

object_name: head and neck neoplasm


subject: UMLS:C2699335

object_name: head and neck cancer


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Nodule of lung


subject: CHEBI:31617

object_name: Multiple Pulmonary Nodules


subject: CHEBI:31617

object_name: Cigarette smoker (finding)


subject: CHEBI:31617

object_name: Smoker


subject: CHEBI:31617

object_name: Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)


subject: CHEBI:31617

object_name: Former smoker


subject: UMLS:C3896904

subject_name: Fluorine F 18 L-glutamate Derivative BAY94-9392


subject: UMLS:C3896904


subject: UMLS:C3896904


subject: UMLS:C3896904


subject: UMLS:C3896904


subject: UMLS:C3896904


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Inflammation


subject: UMLS:C0770246

object_name: Muscle damage


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: cystic fibrosis-related diabetes


subject: PUBCHEM.COMPOUND:73151030

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib

object_name: graft versus host disease


subject: UMLS:C5565994


subject: CHEBI:7421

subject_name: NAC

object_name: altitude sickness


subject: CHEBI:7421

object_name: Effects of high altitude


subject: CHEBI:7421

object_name: Inadequate or impaired breathing pattern or ventilation


subject: CHEBI:7421

object_name: Abnormal blood oxygen pressure


subject: CHEBI:7421

object_name: Hypoxemia


subject: CHEBI:7421

object_name: Hypoxia, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Kinetic tremor


subject: CHEBI:66964

subject_name: Dronabinol


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:172944

subject_name: Cabotegravir

object_name: Pediatric human immunodeficiency virus infection


subject: CHEMBL.COMPOUND:CHEMBL2108628

subject_name: PACLITAXEL POLIGLUMEX

object_name: primary peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: papillary serous cystadenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Recurrent ovarian cancer


subject: CHEBI:36796

subject_name: duloxetine

object_name: biliary dyskinesia


subject: CHEBI:36796

object_name: Sphincter of Oddi dyskinesia


subject: CHEBI:94782

subject_name: Cediranib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:94782

object_name: clear cell renal carcinoma


subject: CHEBI:94782

object_name: renal cell adenocarcinoma


subject: CHEBI:94782

object_name: renal cell carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: transposition of the great arteries


subject: CHEBI:4466

object_name: ventricular septal defect


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:AM9K4SZ3XK

object_name: chronic obstructive pulmonary disease


subject: UMLS:C1541326

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C1541326

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C1541326

object_name: sarcoma


subject: UMLS:C1541326

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C1541326

object_name: soft tissue sarcoma


subject: CHEBI:7772

subject_name: omeprazole

object_name: interstitial lung disease 1


subject: CHEBI:7772

object_name: interstitial lung disease 2


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: punctate inner choroidopathy


subject: UMLS:C1508862

object_name: choroidal neovascularization


subject: UMLS:C1508862

object_name: choroidal neovascularization (physical finding)


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:66910

subject_name: Axitinib

object_name: Recurrent Endometrial Cancer


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: post operative nausea and vomiting


subject: CHEBI:64321

object_name: Complication of anesthesia


subject: CHEBI:64321

object_name: Thoracic Diseases


subject: UNII:9T56TV18X7

object_name: Solid Neoplasm


subject: UNII:9T56TV18X7

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:9T56TV18X7

object_name: non-Hodgkin lymphoma


subject: UNII:9T56TV18X7

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C1330419

subject_name: Niacin ER


subject: UMLS:C1330419


subject: UMLS:C1330419


subject: UMLS:C1330419


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:63632

subject_name: Topotecan

object_name: uterine cancer


subject: CHEBI:63632

object_name: tumor of uterus


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: ovarian cancer


subject: CHEBI:46058

object_name: ovarian neoplasm


subject: CHEBI:46058


subject: CHEBI:46058


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:3207

subject_name: Budesonide

object_name: Snoring


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Anterior segment ischemia


subject: CHEBI:16796

subject_name: Melatonin


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: renal carcinoma


subject: UNII:25E79B5CTM

object_name: kidney neoplasm


subject: UNII:25E79B5CTM

object_name: kidney cancer


subject: UNII:25E79B5CTM

object_name: skin melanoma


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: CHEBI:9150

subject_name: Simvastatin

object_name: acute pancreatitis


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UNII:2285XW22DR

object_name: Esophageal adenocarcinoma stage IV


subject: UNII:2285XW22DR

object_name: Metastatic Esophageal Squamous Cell Carcinoma


subject: UNII:2285XW22DR

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UNII:2285XW22DR

object_name: Recurrent Gastroesophageal Junction Adenocarcinoma


subject: UNII:2285XW22DR

object_name: Oesophageal carcinoma recurrent


subject: UNII:2285XW22DR

object_name: Oesophageal squamous cell carcinoma recurrent


subject: UNII:2285XW22DR

object_name: Oesophageal adenocarcinoma recurrent


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Premenopausal breast cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4672


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:41774

subject_name: Tamoxifen


subject: UMLS:C5441821

subject_name: Farmorubicin

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:47898


subject: RXCUI:1551468

subject_name: 12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet

object_name: obesity due to melanocortin 4 receptor deficiency


subject: RXCUI:1551468

object_name: obesity


subject: RXCUI:1551468

object_name: Obesity, CTCAE


subject: CHEBI:135697

subject_name: Sarpogrelate

object_name: chronic kidney disease


subject: CHEBI:135697

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C3491813


subject: UMLS:C3491813


subject: UMLS:C3491813


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:177883

object_name: Delirium due to sedative withdrawal


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:119915

subject_name: Fentanyl


subject: UMLS:C0596581

subject_name: Fluoropyrimidine

object_name: small intestine adenocarcinoma


subject: CHEBI:61115

subject_name: EC 3.5.1.98 (histone deacetylase) inhibitor

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:61115

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified